1-2 of 2
Hitomi Saso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model

Chandra Bartholomeusz, Xuemei Xie, Mary Kathryn Pitner, Kimie Kondo, Ali Dadbin, Jangsoon Lee, Hitomi Saso, Paul D. Smith, Kevin N. Dalby, Naoto T. Ueno
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (12): 2773–2781.
https://doi.org/10.1158/1535-7163.MCT-15-0243
Published: 06 December 2015
View article titled, MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model
Open the PDF for MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model in another window
Includes: Supplementary data
Journal Articles

MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model

Chandra Bartholomeusz, Tetsuro Oishi, Hitomi Saso, Ugur Akar, Ping Liu, Kimie Kondo, Anna Kazansky, Savitri Krishnamurthy, Jangsoon Lee, Francisco J. Esteva, Junzo Kigawa, Naoto T. Ueno
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 360–369.
https://doi.org/10.1158/1535-7163.MCT-11-0400
Published: 08 February 2012
View article titled, MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model
Open the PDF for MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model in another window